Clinicopathological Study of Epithelial Metaplastic Breast Cancer
- 1 Department of Breast Disease Center, Asahikawa Medical University, Asahikawa, Japan
- 2 Department of Breast Disease Center, Asahikawa Medical University, Asahikawa, Japan
- 3 Department of Breast Disease Center, Asahikawa Medical University, Asahikawa, Japan
- 4 Department of Breast Disease Center, Asahikawa Medical University, Asahikawa, Japan
- 5 Department of Breast Disease Center, Asahikawa Medical University, Asahikawa, Japan
- 6 Department of Breast Disease Center, Asahikawa Medical University, Asahikawa, Japan
Abstract
Introduction : Metaplastic breast cancer (MBC) is a rare pathological type with an incidence rate of not more than 1%, and has been reported to be often detected after its progression and highly malignant with a high proportion of triple negative type tumors, with poor outcomes as compared to IDC [1] [2] [3]. We analyzed clinicopathological characteristics of patients who underwent surgery for epithelial MBC at our department. Patients and Methods : From January 2000 to March 2014, a total of 2120 patients underwent surgery for breast cancer, and MBC was diagnosed in 15 of these patients. Fourteen of the 15 had epithelial MBC and were included in this study. The present study compared clinopathological characteristics of MBC with those of IDC of triple negative type (TN type group) and IDC of non-triple negative type (IDC group). Results : Breast conserving surgery was performed in 7 patients with MBC (50%), a proportion clearly lower than the 64.3% in the IDC group. The mean tumor size was 3.8 cm, which was greater than the 2.13 cm in the TN type group and the 1.7 cm in the IDC group. About nuclear grade, the proportion of grade III was 57.1%, markedly higher than the 38.6% in the TN type group and the 12.6% in the IDC group. All patients were estrogen receptor (ER) and progesterone receptor (PgR) negative; 11 patients were TN type tumors and 3 were HER2 type. Conclusion : We studied patients who underwent surgery for epithelial MBC. The examined cases showed clinopathological characteristics of the disease, including large tumors with a highly malignant nature at the initial detection, higher Ki-67 levels, ER and PgR negativity (all cases), mostly TN type, and a high recurrence rate.
- Beatty, J.D., Atwood, M., Tickman, R. and Reiner, M. (2006) Metaplastic Breast Cancer: Clinical Significance. The American Journal of Surgery, 191, 657-664. https://doi.org/10.1016/j.amjsurg.2006.01.038
- Luini, A., Aguilar, M., Gatti, G., Fasani, R., Botteri, E., Brito, J.A., Maisonneuve, P., Vento, A.R. and Viale, G. (2007) Metaplastic Carcinoma of the Breast, an Unusual Disease with Worse Prognosis: The Experience of the European Institute of Oncology and Review of the Literature. Breast Cancer Research and Treatment, 101, 349-353. https://doi.org/10.1007/s10549-006-9301-1
- Jung, S.Y., Kim, H.Y., Nam, B.H., Min, S.Y., Lee, S.J., Park, C., Kwon, Y., Kim, E.A., Ko, K.L., Shin, K.H., Lee, K.S., Park, I.H., Lee, S., Kim, S.W., Kang, H.S. and Ro, J. (2010) Worse Prognosis of Metaplastic Breast Cancer Patients Than Other Patients with Triple-Negative Breast Cancer. Breast Cancer Research and Treatment, 120, 627-637. https://doi.org/10.1007/s10549-010-0780-8
- Gwin, K., Buell-Gutbrod, R., Tretiakova, M. and Montag, A. (2010) Epithelial-to-Mesenchymal Transition in Metaplastic Breast Carcinomas with Chondroid Differentiation: Expression of the E-Cadherin Repressor Snail. Applied Immunohistochemistry & Molecular Morphology, 18, 526-531. https://doi.org/10.1097/PAI.0b013e3181e8d54b
- Weigelt, B., Kreike, B. and Reis-Filho, J.S. (2009) Metaplastic Breast Carcinomas Are Basal-Like Breast Cancers: A Genomic Profiling Analysis. Breast Cancer Research and Treatment, 117, 273-280. https://doi.org/10.1007/s10549-008-0197-9
- Gerhard, R., Ricardo, S., Albergaria, A., Gomes, M., Silva, A.R., Logullo, A.F., Cameselle-Teijeiro, J.F., Paredes, J. and Schmitt, F. (2012) Immunohistochemical Features of Claudin-Low Intrinsic Subtype in Metaplastic Breast Carcinomas. The Breast, 21, 354-360. https://doi.org/10.1016/j.breast.2012.03.001
- Lester, T.R., Hunt, K.K., Nayeemuddin, K.M., Bassett Jr., R.L., Gonzalez-Angulo, A.M., Feig, B.W., Huo, L., Rourke, L.L., Davis, W.G., Valero, V. and Gilcrease, M.Z. (2012) Metaplastic Sarcomatoid Carcinoma of the Breast Appears More Aggressive Than Other Triple Receptor-Negative Breast Cancers. Breast Cancer Research and Treatment, 131, 41-48.
- Giuliano, M., Giordano, A., Jackson, S., et al. (2011) Circulating Tumor Cells as Prognostic and Predictive Markers in Metastatic Breast Cancer Patients Receiving First-Line Systemic Treatment. Breast Cancer Research, 13, R67. https://doi.org/10.1186/bcr2907
- Lombaerts, M., van Wezel, T., Philippo, K., et al. (2006) E-Cadherin Transcriptional Downregulation by Promoter Methylation But Not Mutation Is Related to Epithelial-to-Mesenchymal Transition in Breast Cancer Cell Lines. British Journal of Cancer, 94, 661-671. https://doi.org/10.1038/sj.bjc.6602996